TabletsTablets
Schedule H (Prescription Required)Neuropathy & Nerve Pain CareCode: 2552

Etoricoxib 60mg + Pregabalin 75mg (SR) Tablets

Generic Formulation:Etoricoxib 60mg and Pregabalin 75mg (SR) Tablets
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹37.5
Brand Estimate*
₹252.55
Estimated Savings:₹215.05 (85% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Pregabalin and Etoricoxib pairs a centrally acting alpha-2-delta ligand with a selective cyclooxygenase-2 (COX-2) inhibitor. Pregabalin dampens neuropathic hyperalgesia and central sensitization, while etoricoxib selectively inhibits inducible COX-2, decreasing peripheral prostaglandin synthesis and localized inflammatory pain. Indicated for mixed nociceptive-neuropathic pain syndromes, severe radiculopathy, sciatica, and refractory spondylitis.

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2552.Report inaccuracy

Usage Guidelines

Take orally once daily with or without food. Swallow whole with a full glass of water. Use the lowest effective dose for the shortest duration necessary.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Peripheral edema, dizziness, headache, hypertension, dyspepsia, somnolence. Rare/Severe: Major adverse cardiovascular events (myocardial infarction, stroke), gastrointestinal ulceration/bleeding, and renal dysfunction.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in active peptic ulcer disease, severe ischemic heart disease, peripheral arterial disease, and uncontrolled hypertension. Regularly monitor blood pressure and renal function.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.